OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,778,757 | -38.2% | 5,343,553 | +1.5% | 0.00% | -100.0% |
| Q2 2023 | $27,156,666 | +4.8% | 5,262,920 | +7.0% | 0.00% | 0.0% |
| Q1 2023 | $25,919,488 | +86.2% | 4,918,309 | -0.7% | 0.00% | – |
| Q4 2022 | $13,917,193 | -30.2% | 4,952,737 | +3.1% | 0.00% | -100.0% |
| Q3 2022 | $19,935,000 | +3.4% | 4,803,961 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $19,278,000 | -23.2% | 4,795,603 | -5.4% | 0.00% | 0.0% |
| Q1 2022 | $25,094,000 | -29.7% | 5,069,321 | -1.0% | 0.00% | 0.0% |
| Q4 2021 | $35,706,000 | -28.2% | 5,122,835 | +3.0% | 0.00% | 0.0% |
| Q3 2021 | $49,720,000 | -29.6% | 4,972,058 | -0.2% | 0.00% | -50.0% |
| Q2 2021 | $70,611,000 | -26.7% | 4,979,612 | -15.1% | 0.00% | -33.3% |
| Q1 2021 | $96,278,000 | -15.6% | 5,867,062 | +6.4% | 0.00% | -25.0% |
| Q4 2020 | $114,103,000 | +267.1% | 5,512,264 | +35.0% | 0.00% | +300.0% |
| Q3 2020 | $31,080,000 | +3.1% | 4,084,064 | +12.9% | 0.00% | 0.0% |
| Q2 2020 | $30,134,000 | +112.8% | 3,617,625 | +26.4% | 0.00% | 0.0% |
| Q1 2020 | $14,162,000 | +26.7% | 2,860,929 | +1.1% | 0.00% | – |
| Q4 2019 | $11,178,000 | +19.7% | 2,829,644 | -7.9% | 0.00% | – |
| Q3 2019 | $9,342,000 | -27.8% | 3,073,274 | +4.5% | 0.00% | -100.0% |
| Q2 2019 | $12,939,000 | +14.6% | 2,940,745 | +3.4% | 0.00% | 0.0% |
| Q1 2019 | $11,287,000 | +1.5% | 2,843,312 | +1.8% | 0.00% | 0.0% |
| Q4 2018 | $11,115,000 | -29.5% | 2,792,752 | +21.8% | 0.00% | 0.0% |
| Q3 2018 | $15,770,000 | +18.8% | 2,292,263 | +16.6% | 0.00% | 0.0% |
| Q2 2018 | $13,270,000 | +20.1% | 1,965,882 | +15.9% | 0.00% | 0.0% |
| Q1 2018 | $11,046,000 | +75.0% | 1,696,612 | +19.6% | 0.00% | – |
| Q4 2017 | $6,312,000 | -27.4% | 1,418,577 | +0.8% | 0.00% | – |
| Q3 2017 | $8,696,000 | -32.0% | 1,407,284 | +2.0% | 0.00% | -100.0% |
| Q2 2017 | $12,794,000 | +6.8% | 1,380,100 | +6.9% | 0.00% | 0.0% |
| Q1 2017 | $11,979,000 | +54350.0% | 1,290,745 | +50537.3% | 0.00% | – |
| Q4 2016 | $22,000 | +175.0% | 2,549 | +118.2% | 0.00% | – |
| Q3 2016 | $8,000 | +33.3% | 1,168 | 0.0% | 0.00% | – |
| Q2 2016 | $6,000 | -33.3% | 1,168 | +18.0% | 0.00% | – |
| Q1 2016 | $9,000 | +200.0% | 990 | +207.5% | 0.00% | – |
| Q4 2015 | $3,000 | -40.0% | 322 | 0.0% | 0.00% | – |
| Q3 2015 | $5,000 | -28.6% | 322 | 0.0% | 0.00% | – |
| Q2 2015 | $7,000 | – | 322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |